Prasterone (CAS 53-43-0) Market Trends：the market size is projected to reach USD 0.08 billion by 2030

Prasterone, the synthetic equivalent of endogenous dehydroepiandrosterone (DHEA), has emerged as a key player in the field of hormone-based therapies. Traditionally recognized for its role in alleviating menopausal symptoms—particularly moderate to severe dyspareunia—it is increasingly being investigated for broader applications including anti-aging, cognitive enhancement, and even immune modulation. With its ability to convert locally into estrogens and androgens, prasterone represents a unique therapeutic modality with minimal systemic exposure, garnering interest from both the medical and wellness communities.

According to the new market research report “Global Prasterone (CAS 53-43-0) Market Research Report 2025”, published by QYResearch, the global Prasterone (CAS 53-43-0) market size is projected to reach USD 0.08 billion by 2030, at a CAGR of 7.1% during the forecast period.

Research institutions and pharmaceutical companies are increasingly exploring prasterone’s potential in areas beyond its current indications, including neuroprotection and metabolic modulation. This diversification is expected to broaden the market scope over the next several years.

In developed markets like the United States and Europe, prasterone is gaining traction as part of a broader trend toward hormone replacement therapies. The aging population’s growing need for treatments that address not only physical but also sexual and cognitive declines is fuelling this demand.

With DHEA levels naturally declining after age 30—more rapidly in women—the need for interventions that restore hormonal balance is becoming more pronounced. This demographic shift is a primary market driver for prasterone-based therapies.

The broader wellness trend, emphasizing holistic health and quality of life improvements, has positioned prasterone as an attractive option for those seeking non-traditional, scientifically backed solutions.

Significant investment in research—both in academia and industry—has accelerated the understanding of prasterone’s multifaceted role, promoting its development as a safer alternative for hormone replacement.

Figure00001. Global Prasterone (CAS 53-43-0) Market Size (US$ Million), 2019-2030

Source: QYResearch, "Global Prasterone (CAS 53-43-0) Market Research Report 2025”

Figure00002. Global Prasterone (CAS 53-43-0) Top 10 Players Ranking and Market Share (Ranking is based on the revenue of 2023, continually updated)

Source: QYResearch, "Global Prasterone (CAS 53-43-0) Market Research Report 2025”

According to QYResearch Top Players Research Center, the global key manufacturers of Prasterone (CAS 53-43-0) include Yicheng Goto Pharmaceutical, Junye Pharmaceutical, Hubei Dan’ao Pharmaceutical, Hubei Zhuxi Humanwell Pharmaceutical, Shandong Saito Biotechnology, etc. In 2023, the global top five players had a share approximately 73.0% in terms of revenue.

According to QYResearch Top Players Research Center, the global key manufacturers of Prasterone (CAS 53-43-0) include Yicheng Goto Pharmaceutical, Junye Pharmaceutical, Hubei Dan’ao Pharmaceutical, Hubei Zhuxi Humanwell Pharmaceutical, Shandong Saito Biotechnology, Jiangsu Jiaerke Pharmaceutical, Zhejiang Shenzhou Pharmaceutical, Wudang Antai Pharmaceutical, Symbiotec, NutriScience Innovations, etc. In 2023, the global top 10 players had a share approximately 87.0% in terms of revenue.

In terms of product type, currently ≥ 99％ is the largest segment, hold a share of 96.5%.

In terms of product application, currently Medicine is the largest segment, hold a share of 76.5%.

About The Authors

About QYResearch

QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 17 years’ experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting (data is widely cited in prospectuses, annual reports and presentations), industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 60,000 clients across five continents. Let’s work closely with you and build a bold and better future.

QYResearch is a world-renowned large-scale consulting company. The industry covers various high-tech industry chain market segments, spanning the semiconductor industry chain (semiconductor equipment and parts, semiconductor materials, ICs, Foundry, packaging and testing, discrete devices, sensors, optoelectronic devices), photovoltaic industry chain (equipment, cells, modules, auxiliary material brackets, inverters, power station terminals), new energy automobile industry chain (batteries and materials, auto parts, batteries, motors, electronic control, automotive semiconductors, etc.), communication industry chain (communication system equipment, terminal equipment, electronic components, RF front-end, optical modules, 4G/5G/6G, broadband, IoT, digital economy, AI), advanced materials industry Chain (metal materials, polymer materials, ceramic materials, nano materials, etc.), machinery manufacturing industry chain (CNC machine tools, construction machinery, electrical machinery, 3C automation, industrial robots, lasers, industrial control, drones), food, beverages and pharmaceuticals, medical equipment, agriculture, etc.

Contact Us:

If you have any queries regarding this report or if you would like further information, please contact us:

QY Research Inc.

Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States

E-mail: global@qyresearch.com

Tel: 001-626-842-1666(US)  0086-133 1872 9947(CN)

EN: https://www.qyresearch.com

JP: https://www.qyresearch.co.jp